One emerging therapy that aligns with our mission of comprehensive perioperative care is BPC -157 peptide therapy
Nausea, vomiting, diarrhea, and constipation are the most frequently reported issues with both peptides
Research Summary by Peptide Key Research Findings by Peptide GHK-CU Research Highlights: Affects expression of over 4,000 genes 36% reduction in fine lines in clinical studies 40-60% faster wound healing vs controls Stimulates collagen I, III, and elastin production Anti-inflammatory and antioxidant effects confirmed AHK-CU Research Highlights: Activates Wnt/-catenin signaling pathway Promotes anagen (growth) phase in hair cycle May reduce DHT through 5-alpha reductase inhibition Improves follicular blood flow SRCP Research Highlights: Enhanced penetration vs first-generation Better stability in formulations Strong wound healing effects Effective scar remodeling For those prioritizing evidence-based choices, GHK-CU has the strongest research foundation
TB-500 (synthetic thymosin -4 fragment, LKKTETQ, 889 Da) shares tissue-healing indications but acts through a different mechanism (G-actin sequestration, Ac-SDKP anti-fibrosis)
On appearance, they look as they always have done
Flagg E